Sex-based association between high-density lipoprotein cholesterol and adverse outcomes after coronary artery bypass grafting

• Published in: BMC cardiovascular disorders 2024-04, Vol.24 (1), p.194-10, Article 194
• Main Authors: Montazeri Namin, Sara, Moradi, Ali, Tavolinejad, Hamed, Vasheghani-Farahani, Ali, Jalali, Arash, Pashang, Mina, Sadeghian, Saeed, Bagheri, Jamshid, Mansourian, Soheil, Mehrani, Mehdi, Hosseini, Kaveh, Rashedi, Sina, Tajdini, Masih
• Format: Article
• Language: English
• Subjects: Acute coronary syndromes; Body mass index; Bypass; Cardiovascular disease; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary artery bypass; Coronary Artery Bypass - adverse effects; Coronary artery bypass graft surgery; Coronary artery disease; Coronary Artery Disease - diagnostic imaging; Coronary Artery Disease - surgery; Coronary vessels; Demographic aspects; Diabetes; Female; Gender differences; Health aspects; Heart attacks; Heart diseases; Heart surgery; High density lipoprotein; High-density lipoprotein cholesterol; Hospitals; Humans; Hypertension; Influence; Ischemia; Major adverse cardiovascular and cerebrovascular events; Male; Males; Mortality; Normal distribution; Patient outcomes; Patients; Population; Population studies; Proportional Hazards Models; Risk Factors; Sex; Statins; Stroke; Transient ischemic attack; Treatment Outcome
• ISSN: 1471-2261; 1471-2261
• DOI: 10.1186/s12872-024-03806-1

High-density lipoprotein cholesterol (HDL-C) is shown to be an independent protective factor against coronary artery diseases (CAD). Yet there are limited studies focusing on the association between HDL-C and coronary artery bypass graft (CABG) surgery outcomes. Low levels of HDL-C are associated with higher incidence of adverse outcomes in patients undergoing CABG. This registry-based study included 17,772 patients who underwent elective isolated CABG between 2007 and 2017. Patients were classified into low and desirable HDL-C groups based on their serum HDL-C levels at admission and were followed for one-year post-surgery. The study population included 13,321 patients with low HDL-C and 4,451 with desirable HDL-C. proportional hazard Cox models were performed to evaluate the association between HDL-C levels and incidence of mortality as well as major adverse cardiovascular and cerebrovascular events (MACCE), while adjusting for potential confounders. Moreover, participants were stratified based on sex and the association was also investigated in each subgroup separately. No significant difference was found between the groups regarding incidence of both mortality and MACCE, after adjusting with Inverse Probability Weighting (IPW) [HR (95%CI): 0.84 (0.46-1.53), p-value:0.575 and HR (95% CI): 0.91 (0.56-1.50), p-value:0.733, respectively]. According to the sex-based subgroup analysis, no significant association was observed after adjustment with IPW analysis. However, as we examined the association between the interaction of HDL-C levels, sex and cardiovascular outcomes, we found a significant association (HR;1.19 (95%CI: 1.04-1.45); p = 0.030). HDL-C level was not associated with either mortality or MACCE during one year after CABG procedure. Sex-based analysis showed that in males, HDL-C is significantly more protective against these outcomes, compared to females. Further studies are necessary to elucidate the exact mechanisms mediating such association.